living medicine

This shows a cross-section of a mouse lung infected with Pseudonomas aeruginosa. The mouse was treated with a version of Mycoplasma pneumoniae that is able to produce therapeutic molecules such as pyocins specifically-designed to combat P. aeruginosa. This therapeutic version of M. pneumoniae acts like a ‘living medicine’ reducing the effects of the infection and preserving air in the alveoli. CREDIT Rocco Mazzolini/CRG
The first “living medicine” to treat lung infections
The first ‘living medicine’ to treat antibiotic-resistant bacteria growing on the surfaces of medical implants